2nd Annual Research Symposium

October 2018

IMG-6913.JPG

Jean-Frederic Colombel MD

The Mount Sinai Hospital

Key Note Address:

The Spirit of Collaboration: From GETAID to NYCCO

IMG-6932.JPG

Jordan Axelrad MD

NYU Langone Medical Center

Risk of New or Recurrent Cancer in Patients With IBD and Previous Cancer

IMG-6922.JPG

Galen Leung MD

Stonybrook University Medical Center

Managing Infliximab Re-introduction after Temporary Discontinuation of Drug: a Retrospective Multicentric Study

Keith Sultan MD

Northwell Health

Utilization  of Serologic and Genetic Testing in the Diagnosis and Management of  IBD: A Physician Survey

Robert Hirten MD

The Mount Sinai Hospital

Anastomotic Ulcers After Ileocolic Resection Predict Crohn's Disease Recurrence

Ryan Ungaro.JPG

Ryan Ungaro MD

The Mount Sinai Hospital

Stopping 5-Aminosalicylates in IBD Patients Starting Biologic Therapy Does Not Increase the Risk of Adverse Clinical Outcomes: Analysis of Two Nationwide of Population-Based Cohorts

IMG-6941.JPG

Adam Tepler MD

Montefiore Medical Center

The Impact of Delay in Clostridium difficile Testing on Outcomes in IBD Patients Hospitalized with Gastrointestinal Symptoms

IMG-6927.JPG

Qin Rao MD

Stonybrook University Medical Center

A Study of the Risk Factors for Hospital Admissions in IBD and the Differences between Crohn’s Disease and Ulcerative Colitis Admissions in a Large Tertiary Care Center